Tesla's Optimus humanoid robot has become a critical piece of the company's long-term investment thesis, yet the timeline for mass production and commercialization remains uncertain, creating a valuation gap that investors are beginning to scrutinize. While Tesla initially planned to unveil the production-ready Gen 3 version in the first quarter of 2026, the company has since pushed that reveal to July or August, signaling that design refinements are still underway even as competitors move aggressively toward their own launches.

Why Is Optimus So Important to Tesla's Stock Price?

Optimus represents one of Tesla's most ambitious bets beyond electric vehicles. Analysts and investors increasingly view humanoid robotics as a market that could eventually exceed the automotive industry in size, making the robot a key driver of Tesla's future earnings potential. The company's current valuation, which trades at a 15X sales multiple compared to SpaceX's 94X multiple, already prices in meaningful upside from Optimus, Robotaxis, and artificial intelligence initiatives.

However, the delayed timeline raises questions about execution risk. Tesla's ability to move from prototype to mass production at scale has historically been strong in the automotive sector, but robotics presents a fundamentally different manufacturing and supply chain challenge. The company faces several critical hurdles:

• Design Refinement: Tesla has not yet finalized the production design, with Elon Musk indicating that some refinements are still being completed before the July or August reveal.
• Manufacturing Scale: Moving from limited prototypes to mass production requires entirely new production lines, supply chain partnerships, and quality control systems that Tesla has not yet publicly detailed.
• Competitive Pressure: Chinese competitors like XPeng are aggressively pursuing their own humanoid robots, with plans to begin trials and commercialization within similar timeframes.

How Are Competitors Accelerating Their Robotics Programs?

XPeng, Tesla's primary competitor in the Chinese electric vehicle market, has taken a significant step by placing its CEO He Xiaopeng in direct leadership of its robotics division. The company announced that it aims to begin mass production of its IRON humanoid robot by the end of 2026, with commercial availability in China expected from 2027.

"The (robot) industry is becoming increasingly hot and competitive, and we have clearly seen the direction and timing of victory, but it still requires more arduous implementation and extremely high decision-making ability," stated He Xiaopeng, CEO of XPeng.

He Xiaopeng, CEO at XPeng

This move signals that XPeng views robotics as strategically critical enough to warrant CEO-level attention. The company's IRON robot features human-like movement capabilities, flexible skin, and a curved display integrated into its head, powered by XPeng's proprietary artificial intelligence technology and Turing chips. The robot will initially be deployed in commercial service applications, with trials planned in XPeng's retail stores before broader commercialization.

The timing is notable. XPeng's mass production target of end-2026 aligns closely with Tesla's revised timeline for the Optimus Gen 3 reveal in July or August 2026. This means both companies are racing toward similar milestones within the same window, intensifying competitive pressure on execution and manufacturing capability.

What Does This Mean for Tesla's Investment Case?

Tesla's valuation advantage over SpaceX rests partly on the assumption that the company can successfully commercialize Optimus, Robotaxis, and its energy storage business while maintaining profitability. Current earnings estimates project Tesla's earnings per share will rise 20 percent in fiscal 2026 and another 28 percent in fiscal 2027 to $2.56 per share.

However, recent estimate revisions tell a cautionary tale. Over the last 60 days, Tesla's fiscal 2026 earnings per share estimates have slightly declined, while fiscal 2027 estimates have dropped by roughly 5 percent. This suggests that analysts are becoming more conservative about near-term execution, even as the company maintains its long-term growth narrative.

The delayed Optimus reveal and XPeng's aggressive push into mass production create a scenario where Tesla's first-mover advantage in robotics is narrowing. If XPeng successfully launches IRON robots in China by 2027, it could establish a significant foothold in a market where Tesla has limited manufacturing presence. Conversely, if Tesla accelerates Optimus production and achieves meaningful commercialization in the United States and globally, the company's valuation could prove justified.

For investors, the key question is whether Tesla's current valuation reflects the execution risks inherent in launching a new product category at scale. The company trades at a significantly lower multiple than SpaceX, offering what some analysts describe as a "greater margin of safety" if growth expectations take longer to materialize. Yet the narrowing timeline between Tesla's Optimus reveal and XPeng's mass production push suggests that the margin of safety may be shrinking as competitive intensity increases.